Latest News

COVID vaccine guidance for MS patients


The Canadian Network of MS Clinics has endorsed a COVID vaccination guidance document developed by the U.S. National MS Society (see links below). The advice is based on expert opinion due to a lack of data on the safety and efficacy of the COVID vaccine in the multiple sclerosis population and applies only to the mRNA vaccines (Pfizer, Moderna) currently available.

Read More

Multiple sclerosis 2021 – a look ahead


Click here to take the survey

To start off the new year, NeuroSens asked some MS experts from across Canada what developments in multiple sclerosis research and management we can expect to see. Some issues were necessarily related to COVID-21. But the prognosticators also identified several important questions that may be answered in the months ahead.

Read More